Differential protein synthesis and expression levels in normal and neoplastic human prostate cells and their regulation by type I and II interferons

Oncogene

Volumn 23, Issue 9, 2004, Pages 1693-1703

  Nagano, Kohji ^a,c   Masters, John R ^a   Akpan, Akunna ^a   Yang, Alice ^a   Corless, Steve ^a   Wood, Chris ^a   Hastie, Claire ^a   Zvelebil, Marketa ^a,b   Cramer, Rainer ^a,b   Naaby Hansen, Soren ^a,b  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

Growth inhibitory effect of interferon; Interferon treatment; Prostate cancer

Indexed keywords

ALPHA INTERFERON; GAMMA INTERFERON; INTERFERON; MYC PROTEIN; MYXOVIRUS RESISTANCE PROTEIN A; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN; PROTEIN IFP53; PROTEIN ISGF3GAMMA; PROTEIN KINASE B; PROTEIN NMI; PROTEIN PA28A; UNCLASSIFIED DRUG; CARRIER PROTEIN; DNA BINDING PROTEIN; EPIDERMAL GROWTH FACTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN K; INTERFERON REGULATORY FACTOR 9; INTERFERON STIMULATED GENE FACTOR 3; ISGF3G PROTEIN, HUMAN; MITOGEN ACTIVATED PROTEIN KINASE; MYXOVIRUS RESISTANCE PROTEINS; NMI PROTEIN, HUMAN; PROTEOME; SIGNAL PEPTIDE; TRANSCRIPTION FACTOR;

ARTICLE; CANCER CELL; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; HUMAN; HUMAN CELL; MASS SPECTROMETRY; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN INDUCTION; PROTEIN SYNTHESIS; PROTEOMICS; QUALITY CONTROL; BIOSYNTHESIS; CELL DIVISION; CELL LINE; COMPARATIVE STUDY; CYTOLOGY; DRUG EFFECT; ELECTROSPRAY MASS SPECTROMETRY; ENZYMOLOGY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; MALE; METABOLISM; PATHOLOGY; PHOSPHORYLATION; PROSTATE; PROSTATE TUMOR; SIGNAL TRANSDUCTION; TUMOR CELL LINE; TWO DIMENSIONAL GEL ELECTROPHORESIS;

1-PHOSPHATIDYLINOSITOL 3-KINASE; CARRIER PROTEINS; CELL DIVISION; CELL LINE; CELL LINE, TUMOR; DNA-BINDING PROTEINS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; EPIDERMAL GROWTH FACTOR; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GTP-BINDING PROTEINS; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEIN K; HUMANS; INTERFERON TYPE II; INTERFERON-ALPHA; INTERFERON-STIMULATED GENE FACTOR 3; INTERFERON-STIMULATED GENE FACTOR 3, GAMMA SUBUNIT; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROSTATE; PROSTATIC NEOPLASMS; PROTEOME; SIGNAL TRANSDUCTION; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TRANSCRIPTION FACTORS;

EID: 1642291861     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207297     Document Type: Article

References (45)

1. Bannasch D, Weis I and Schwab M. (1999). Oncogene, 18, 6810-6817.
2. Bao J and Zervos AS. (1996). Oncogene, 12, 2171-2176.
3. Barbosa-Tessmann IP, Chen C, Zhong C, Siu F, Schuster SM, Nick HS and Kilberg MS. (2000). J. Biol. Chem., 275, 26976-26985.
4. Benvenuti S, Cramer R, Quinn CC, Bruce J, Zvelenil M, Corless S, Bond J, Yang A, Hockfield S, Burlingame AL, Waterfield MD and Jat PS. (2002). Mol. Cell Proteomics, 1, 280-292.
5. Braddock DT, Baber JL, Levens D and Clore GM. (2002). EMBO J., 21, 3476-3485.
6. Bright RK, Vocke CD, Emmert-Buck MR, Duray PH, Solomon D, Fetsch P, Rhim JS, Linehan WM and Topalian SL. (1997). Cancer Res., 57, 995-1002.
7. Bomsztyk K, Van Seuningen I, Suzuki H, Denisenko O and Ostrowski J. (1997). FEBS Lett., 403, 113-115.
8. Da Silva N, Bharti A and Shelley CS. (2002). Blood, 100, 3536-3544.
9. Delom F, Mallet B, Carayon P and Lejeune PJ. (2001). J. Biol. Chem., 276, 21337-21342.
10. Entwistle A and Noble M. (1994). J. Microsc., 175, 238-251.
11. Frigerio L and Lord JM. (2000). Curr. Biol., 10, R674-R677.
12. Habelhah H, Shah K, Huang L, Ostareck-Lederer A, Burlingame AL, Shokat KM, Hentze MW and Ronai Z. (2001). Nat. Cell Biol., 3, 325-330.
13. Isaacs W, De Marzo A and Nelson WG. (2002). Cancer Cell, 2, 113-116.
14. Kopito R. (1997). Cell, 88, 427-430.
15. Kuratsukuri K, Nishisaka N, Jones RF, Wang CY and Haas GP. (2000). Urol. Oncol., 5, 265-273.
16. Maki RG, Old LJ and Srivastava PK. (1990). Proc. Natl. Acad. Sci. USA, 87, 5658-5662.
17. Mandal M, Vadlamudi R, Nguyen D, Wang RA, Costa L, Bagheri-Yarmand R, Mendelsohn J and Kumar R. (2001). J. Biol. Chem., 276, 9699-9704.
18. Naaby-Hansen S, Waterfield MD and Cramer R. (2001). Trends Pharmacol Sci., 22, 376-384.
19. Naaby-Hansen S, Nagano K, Gaffney P, Masters JRW and Cramer R. (2003). Proteomics in the Analysis of Prostate Cancer, Russell PJ, Jackson P and Kingsley EA (eds). Humana Press: Totowa, NJ, pp. 277-298.
20. Nakaya T, Sato M, Hata N, Asagiri M, Suemori H, Noguchi S, Tanaka N and Taniguchi T. (2001). Biochem. Biophys. Res. Commun., 283, 1150-1156.
21. Nakielny S and Dreyfuss G. (1999). Cell, 99, 677-690.
22. Nesterov A, Lu X, Johnson M, Miller GJ, Ivashchenko Y and Kraft S. (2001). J. Biol. Chem., 276, 10767-10774.
23. Ostareck DH, Ostareck-Lederer A, Wilm M, Thiele BJ, Mann M and Hentze MW. (1997). Cell, 89, 597-606.
24. Ostareck-Lederer A, Ostareck DH, Cans C, Neubauer G, Bomsztyk K, Superti-Furga G and Hentze MW. (2002). Mol. Cell. Biol., 22, 4535-4543.
25. Page MJ, Amess B, Townsend RR, Parekh R, Herath A, Brusten L, Zvelebil MJ, Stein RC, Waterfield MD, Davies SC and O'Hare MJ. (1999). Proc. Natl. Acad. Sci. USA, 96, 12589-12594.
26. Ramana CV, Grammatikakis N, Chernov M, Nguyen H, Goh KC, Williams BRG and Stark GR. (2000). EMBO J., 19, 263-272.
27. Roberts WW, Bergstralh EJ, Blute ML, Slezak JM, Carducci M, Han M, Epstein JI, Eisenberger MA, Walsh PC and Partin AW. (2001). Urology, 57, 1033-1037.
28. Rock KL and Goldberg AL. (1999). Annu. Rev. Immunol., 17, 739-779.
29. Sampath P, Mazumder B, Seshadri V and Fox PL. (2003). Mol. Cell. Biol., 23, 1509-1519.
30. Scadden ADJ and Naaby-Hansen S. (2001). Methods Enzymol., 341, 126-141.
31. Shevchenko A, Wilm M, Vorm O and Mann M. (1996). Anal. Chem., 68, 850-858.
32. Shou J, Soriano R, Hayward SW, Cunha GR, Williams PM and Gao WQ. (2002). Proc. Natl. Acad. Sci. USA, 99, 2830-2835.
33. Singh D, Febbo PG, Ross K, Jackson DG, Manola J, Ladd C, Tamayo P, Renshaw AA, D'Amico AV, Richie JP, Lander ES, Loda M, Kantoff PW, Golub TR and Sellers WR. (2002). Cancer Cell, 1, 203-209.
34. Sueoka E, Goto Y, Sueoka N, Kai Y, Kozu T and Fujiki H. (1999). Cancer Res., 59, 1404-1407.
35. Suto R and Srivastava PK. (1995). Science, 269, 1585-1588.
36. Tirasophon W, Welihinda AA and Kaufman RJ. (1998). Genes Dev., 12, 1812-1824.
37. Tomonaga T and Levens D. (1995). J. Biol. Chem., 270, 4875-4881.
38. Tran Quang C, Gautreau A, Arpin M and Treisman R. (2000). EMBO J., 19, 4565-4576.
39. Van Seuningen I, Ostrowski J, Bustelo XR, Sleath PR and Bomsztyk K. (1995). J. Biol. Chem., 270, 26976-26985.
40. Vigneswaran N, Zhao W, Dassanayake A, Muller S, Miller DM and Zacharias W. (2000). Hum. Pathol., 31, 931-937.
41. Weijerman PC, Konig JJ, Wong ST, Niesters HG and Peehl DM. (1994). Cancer Res., 54, 5579-5583.
42. Wojciak-Stothard B, Williams L and Ridley AJ. (1999). J. Cell Biol., 145, 1293-1307.
43. Wu YX, Uezato T and Fujita M. (2000). J. Cell. Biochem., 79, 311-321.
44. Yu Z, Fotouhi-Ardakani N, Wu L, Maoui M, Wang S, Banville D and Shen SH. (2002). J. Biol. Chem., 277, 40247-40252.
45. Zhu M, John S, Berg M and Leonard WJ. (1999). Cell, 96, 121-130.